Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Jérémie Richard

67 indexed publications match this author name.

ORCID
0000-0001-9893-1353
OpenAlex
https://openalex.org/A5006203775

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.International Journal of Eating Disorders · 2026-07-01Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Unknown journal · 2026-05-28Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescenceNeuropsychopharmacology · 2026-02-17Electrical brain changes following psilocybin administration in sprague-dawley ratsNeuroscience Applied · 2025-12-31The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.Current oncology (Toronto, Ont.) · 2025-12-21The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.Journal of psychoactive drugs · 2025-11-08Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-10-31Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialPilot and Feasibility Studies · 2025-10-27Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-09-30High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley ratsJournal of Psychopharmacology · 2025-09-21Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility studyAddiction · 2025-09-19Active Constituents of Psilocybin Mushroom EdiblesJAMA Network Open · 2025-09-10Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trialGeneral Hospital Psychiatry · 2025-08-11Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World ReligionsPsychedelic Medicine · 2025-05-15Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-23The Rise of Psilocybin Use in the United States: A Multisource Observational StudyAnnals of Internal Medicine · 2025-04-20458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene ExpressionBiological Psychiatry · 2025-04-08Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)Journal of Pharmacology and Experimental Therapeutics · 2025-02-28Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal SurveyDrug and Alcohol Dependence · 2025-01-31Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trialPLoS ONE · 2025-01-16Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.Unknown journal · 2025-01-15Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical TrialAmerican Journal of Psychiatry · 2024-12-31Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.Unknown journal · 2024-11-26The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-21Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancerNature Mental Health · 2024-10-06PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trialInternational Journal of Gynecological Cancer · 2024-09-30Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trialScientific Reports · 2024-04-16Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorderCancer · 2023-12-17Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiencesScientific Reports · 2023-08-21Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility StudyJournal of Palliative Medicine · 2023-08-16How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of changeJournal of Affective Disorders · 2023-05-02Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression DisorderJAMA Oncology · 2023-04-12Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-07-31Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other BenefitsPsychiatric News · 2022-05-22Increased global integration in the brain after psilocybin therapy for depression.Nature Medicine · 2022-04-10Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science Advances · 2021-11-16Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.ACS Pharmacology & Translational Science · 2021-03-17Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.Unknown journal · 2020-07-24Long-Term Analysis of Psilocybin in Cancer Patients With DistressOncology Times · 2020-03-25S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in “Magic” MushroomsChemBioChem · 2019-12-03The Potential of Psilocybin Administration in Terminal Cancer PatientsOncology Times · 2019-06-27Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.International review of psychiatry (Abingdon, England) · 2018-07-31Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of Psychopharmacology · 2017-10-10Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of Psychopharmacology · 2016-11-30Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia Bulletin · 2012-10-07Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British Journal of Psychiatry · 2012-01-25Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences · 2012-01-22Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.Psychopharmacology · 2011-06-14Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.Journal of Neuroscience · 2011-01-31Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.Journal of Psychopharmacology · 2008-06-30The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by PsilocybinArchive for the Psychology of Religion · 2007-12-31Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.Psychopharmacology · 2006-07-06The genus psilocybeJournal of Ethnopharmacology · 1984-04-30Psilocybin-Induced Transformations of Visual SpacePharmacopsychiatry · 1970-06-30Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial DistortionPharmacopsychiatry · 1969-10-31Botanical and Chemical Characterisation of a Forensic Mushroom Specimen of the Genus PsilocybeJournal of the Forensic Science Society · 1966-06-30Psilocybin in psychiatry, and beyond.Unknown journal · 1960-12-31Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen RauschpilzenHelvetica Chimica Acta · 1958-12-31Psilocybin, an active psychotropic material from the Mexican hallucinogenic fungus.Unknown journal · 1957-12-31The determination of the formation of the carpophores and sclerotia in culture of Psilocybe mexicana Heim, a Mexican, hallucinogenic agaric, and the demonstration of the presence of psilocybin and psilocin.Unknown journal · 1957-12-31

Author directory

Carhart-Harris RL.58 publicationsVollenweider FX51 publicationsCarhart-Harris R50 publicationsGriffiths RR50 publicationsNutt DJ49 publicationsJohnson MW44 publicationsErritzoe D42 publicationsRoseman L41 publicationsRobin Carhart-Harris39 publicationsBarrett FS.34 publicationsPreller KH33 publicationsJohns Hopkins University31 publicationsKnudsen GM30 publicationsNutt D28 publicationsHendricks PS27 publicationsDavid Erritzøe25 publicationsRoland R. Griffiths25 publicationsGarcia-Romeu A23 publicationsDavid Nutt22 publicationsFranz X. Vollenweider22 publicationsGitte M. Knudsen22 publicationsPáleníček T.22 publicationsRosenblat JD22 publicationsFisher PM21 publicationsDavis AK20 publicationsDea Siggaard Stenbæk19 publicationsKargbo RB.19 publicationsKatrin H. Preller19 publicationsMcIntyre RS.19 publicationsStenbæk DS19 publicationsTimmermann C19 publicationsDos Santos RG18 publicationsLiechti ME18 publicationsPatrick M. Fisher18 publicationsRoss S18 publicationsYaden DB18 publicationsDeco G17 publicationsDirk Hoffmeister17 publicationsHusain MI17 publicationsKuypers KPC.17 publicationsM. Madsen17 publicationsMatthew W. Johnson17 publicationsSimonsson O17 publicationsTomáš Páleníček17 publicationsKringelbach ML.16 publicationsOzenne B16 publicationsSeifritz E16 publicationsBrice Ozenne15 publicationsFischer R.15 publicationsFrederick S. Barrett15 publicationsGonzález-Maeso J15 publicationsGuy M. Goodwin15 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsKwan AC.15 publicationsMadsen MK15 publicationsMason NL.15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsYale University15 publicationsAlbert Garcia-Romeu14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKometer M14 publicationsNayak SM14 publicationsBasel13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsManish Agrawal13 publicationsNathan D. Sepeda13 publicationsSandeep M. Nayak13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsJames Rucker12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMcCulloch DE12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsBenyamina A11 publicationsBouso JC.11 publicationsGouzoulis-Mayfrank E11 publicationsHolze F11 publicationsJoshua Woolley11 publicationsKaelen M11 publicationsMartin Kuchař11 publicationsMuhammad Ishrat Husain11 publicationsNichols CD.11 publicationsOsika W11 publicationsScott T. Aaronson11 publicationsStephen Ross11 publicationsWang X.11 publicationsAnderson BT10 publicationsBarnett BS10 publicationsDavoudian PA10 publicationsErica Kaczmarek10 publicationsHoráček J10 publicationsHouman Farzin10 publicationsKovar KA.10 publicationsMatthias E. Liechti10 publicationsMichael P. Bogenschutz10 publicationsRoger S. McIntyre10 publicationsSchmid Y10 publicationsSchoevers RA10 publicationsUniversity of California10 publicationsVohryzek J10 publicationsZoe Doyle10 publicationsAaronson ST9 publicationsAndrea Mattarei9 publicationsArmand S9 publicationsBotvinnik A9 publications